<VariationArchive VariationID="3203" VariationName="NM_001079802.2(FKTN):c.1167dup (p.Phe390fs)" VariationType="Duplication" Accession="VCV000003203" Version="76" RecordType="classified" NumberOfSubmissions="16" NumberOfSubmitters="14" DateLastUpdated="2024-07-29" DateCreated="2014-10-06" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18242" VariationID="3203">
      <GeneList>
        <Gene Symbol="FKTN" FullName="fukutin" GeneID="2218" HGNC_ID="HGNC:3622" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="105558130" stop="105641118" display_start="105558130" display_stop="105641118" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="108320410" stop="108403398" display_start="108320410" display_stop="108403398" Strand="+" />
          </Location>
          <OMIM>607440</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001079802.2(FKTN):c.1167dup (p.Phe390fs)</Name>
      <CanonicalSPDI>NC_000009.12:105620049:AAAAAAA:AAAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="105620049" stop="105620050" display_start="105620049" display_stop="105620050" variantLength="1" positionVCF="105620049" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="108382330" stop="108382331" display_start="108382330" display_stop="108382331" variantLength="1" positionVCF="108382330" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>F258fs</ProteinChange>
      <ProteinChange>F367fs</ProteinChange>
      <ProteinChange>F390fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.108382337dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.108382337dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.105620056dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.105620056dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008754.1" sequenceAccession="NG_008754" sequenceVersion="1" change="g.66927dup">
            <Expression>NG_008754.1:g.66927dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079802.2" sequenceAccession="NM_001079802" sequenceVersion="2" change="c.1167dup" MANESelect="true">
            <Expression>NM_001079802.2:c.1167dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001073270.1" sequenceAccession="NP_001073270" sequenceVersion="1" change="p.Phe390fs">
            <Expression>NP_001073270.1:p.Phe390fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001198963.2" sequenceAccession="NM_001198963" sequenceVersion="2" change="c.1167dup">
            <Expression>NM_001198963.2:c.1167dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001185892.1" sequenceAccession="NP_001185892" sequenceVersion="1" change="p.Phe390fs">
            <Expression>NP_001185892.1:p.Phe390fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351496.2" sequenceAccession="NM_001351496" sequenceVersion="2" change="c.1167dup">
            <Expression>NM_001351496.2:c.1167dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338425.1" sequenceAccession="NP_001338425" sequenceVersion="1" change="p.Phe390fs">
            <Expression>NP_001338425.1:p.Phe390fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351497.2" sequenceAccession="NM_001351497" sequenceVersion="2" change="c.1098dup">
            <Expression>NM_001351497.2:c.1098dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338426.1" sequenceAccession="NP_001338426" sequenceVersion="1" change="p.Phe367fs">
            <Expression>NP_001338426.1:p.Phe367fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351498.2" sequenceAccession="NM_001351498" sequenceVersion="2" change="c.1167dup">
            <Expression>NM_001351498.2:c.1167dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338427.1" sequenceAccession="NP_001338427" sequenceVersion="1" change="p.Phe390fs">
            <Expression>NP_001338427.1:p.Phe390fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351499.2" sequenceAccession="NM_001351499" sequenceVersion="2" change="c.771dup">
            <Expression>NM_001351499.2:c.771dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338428.1" sequenceAccession="NP_001338428" sequenceVersion="1" change="p.Phe258fs">
            <Expression>NP_001338428.1:p.Phe258fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351500.2" sequenceAccession="NM_001351500" sequenceVersion="2" change="c.771dup">
            <Expression>NM_001351500.2:c.771dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338429.1" sequenceAccession="NP_001338429" sequenceVersion="1" change="p.Phe258fs">
            <Expression>NP_001338429.1:p.Phe258fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351501.2" sequenceAccession="NM_001351501" sequenceVersion="2" change="c.771dup">
            <Expression>NM_001351501.2:c.771dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338430.1" sequenceAccession="NP_001338430" sequenceVersion="1" change="p.Phe258fs">
            <Expression>NP_001338430.1:p.Phe258fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351502.2" sequenceAccession="NM_001351502" sequenceVersion="2" change="c.771dup">
            <Expression>NM_001351502.2:c.771dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338431.1" sequenceAccession="NP_001338431" sequenceVersion="1" change="p.Phe258fs">
            <Expression>NP_001338431.1:p.Phe258fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006731.2" sequenceAccession="NM_006731" sequenceVersion="2" change="c.1167dup">
            <Expression>NM_006731.2:c.1167dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006722.2" sequenceAccession="NP_006722" sequenceVersion="2" change="p.Phe390fs">
            <Expression>NP_006722.2:p.Phe390fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_147213.2" sequenceAccession="NR_147213" sequenceVersion="2" change="n.1118dup">
            <Expression>NR_147213.2:n.1118dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_147214.2" sequenceAccession="NR_147214" sequenceVersion="2" change="n.1290dup">
            <Expression>NR_147214.2:n.1290dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_434" sequenceAccession="LRG_434">
            <Expression>LRG_434:g.66927dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_434t2" sequenceAccession="LRG_434t2">
            <Expression>LRG_434t2:c.1167dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_434p2" sequenceAccession="LRG_434p2" change="p.Phe390fs">
            <Expression>LRG_434p2:p.Phe390fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006731.2" sequenceAccession="NM_006731" sequenceVersion="2" change="c.1167dupA">
            <Expression>NM_006731.2:c.1167dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079802.1" sequenceAccession="NM_001079802" sequenceVersion="1" change="c.1167dupA">
            <Expression>NM_001079802.1:c.1167dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA116060" DB="ClinGen" />
        <XRef ID="GTR000591218" DB="Genetic Testing Registry (GTR)" />
        <XRef ID="GTR000604059" DB="Genetic Testing Registry (GTR)" />
        <XRef Type="Allelic variant" ID="607440.0005" DB="OMIM" />
        <XRef Type="rs" ID="398123555" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 10545611 Fig. 3 to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001079802.2(FKTN):c.1167dup (p.Phe390fs) AND Autosomal recessive limb-girdle muscular dystrophy type 2M" Accession="RCV000003357" Version="15">
        <ClassifiedConditionList TraitSetID="822">
          <ClassifiedCondition DB="MedGen" ID="C1969040">Autosomal recessive limb-girdle muscular dystrophy type 2M</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-03-21" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001079802.2(FKTN):c.1167dup (p.Phe390fs) AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4" Accession="RCV000003356" Version="14">
        <ClassifiedConditionList TraitSetID="6475">
          <ClassifiedCondition DB="MedGen" ID="C0410174">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-05-06" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001079802.2(FKTN):c.1167dup (p.Phe390fs) AND not provided" Accession="RCV000079427" Version="28">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-04-29" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001079802.2(FKTN):c.1167dup (p.Phe390fs) AND Walker-Warburg congenital muscular dystrophy" Accession="RCV000634081" Version="17">
        <ClassifiedConditionList TraitSetID="31131">
          <ClassifiedCondition DB="MedGen" ID="C0265221">Walker-Warburg congenital muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-31" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001079802.2(FKTN):c.1167dup (p.Phe390fs) AND FKTN-related disorder" Accession="RCV000778871" Version="12">
        <ClassifiedConditionList TraitSetID="47333">
          <ClassifiedCondition>FKTN-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-11-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001079802.2(FKTN):c.1167dup (p.Phe390fs) AND Cardiovascular phenotype" Accession="RCV002326661" Version="9">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001079802.2(FKTN):c.1167dup (p.Phe390fs) AND multiple conditions" Accession="RCV002476917" Version="8">
        <ClassifiedConditionList TraitSetID="11608">
          <ClassifiedCondition DB="MedGen" ID="C1969040">Autosomal recessive limb-girdle muscular dystrophy type 2M</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1969024">Dilated cardiomyopathy 1X</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0410174">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4284790">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2751052">Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001079802.2(FKTN):c.1167dup (p.Phe390fs) AND Dilated cardiomyopathy 1X" Accession="RCV003466792" Version="2">
        <ClassifiedConditionList TraitSetID="821">
          <ClassifiedCondition DB="MedGen" ID="C1969024">Dilated cardiomyopathy 1X</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-04-29" NumberOfSubmissions="16" NumberOfSubmitters="14" DateCreated="2014-10-06" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10545611</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17044012</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17878207</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18177472</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18752264</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19266496</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24144914</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27065010</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="822" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3235" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy-dystroglycanopathy, type C4</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C4/8753" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4</ElementValue>
                <XRef Type="MIM" ID="611588" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607440.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607440.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607440.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607440.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607440.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2M</ElementValue>
                <XRef ID="MONDO:0012699" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2M</ElementValue>
                <XRef Type="MIM" ID="611588" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MDDGC4</ElementValue>
                <XRef Type="MIM" ID="611588" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LGMD2M</ElementValue>
                <XRef Type="MIM" ID="611588" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12538" />
                <XRef ID="12538" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="206554" DB="Orphanet" />
              <XRef ID="C1969040" DB="MedGen" />
              <XRef ID="MONDO:0012699" DB="MONDO" />
              <XRef Type="MIM" ID="611588" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="821" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="717" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">FKTN-Related Dilated Cardiomyopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARDIOMYOPATHY, DILATED, WITH MILD OR NO PROXIMAL MUSCLE WEAKNESS</ElementValue>
                <XRef Type="MIM" ID="611615" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dilated cardiomyopathy 1X</ElementValue>
                <XRef ID="MONDO:0012704" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMD1X</ElementValue>
                <XRef Type="MIM" ID="611615" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15522" />
                <XRef ID="15522" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301486</ID>
                <ID Source="BookShelf">NBK1309</ID>
              </Citation>
              <XRef ID="154" DB="Orphanet" />
              <XRef ID="C1969024" DB="MedGen" />
              <XRef ID="MONDO:0012704" DB="MONDO" />
              <XRef Type="MIM" ID="611615" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="31131" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="35635" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy-dystroglycanopathy, type A</ElementValue>
                <XRef ID="MONDO:0000171" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS236670" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Walker-Warburg syndrome</ElementValue>
                <XRef ID="899" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Walker-Warburg congenital muscular dystrophy</ElementValue>
                <XRef ID="Walker-Warburg+syndrome/7436" DB="Genetic Alliance" />
                <XRef ID="111504002" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2599" />
                <XRef ID="2599" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C0265221" DB="MedGen" />
              <XRef ID="MONDO:0000171" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS236670" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="11608" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1903" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4</ElementValue>
                <XRef ID="MONDO:0009678" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, FKTN-RELATED</ElementValue>
                <XRef Type="MIM" ID="253800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, congenital progressive, with mental retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, congenital, with central nervous system involvement</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebromuscular dystrophy, Fukuyama type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fukuyama type muscular dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Walker-Warburg Syndrome, Fktn-Related</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fukuyama congenital muscular dystrophy</ElementValue>
                <XRef ID="Fukuyama+Type+Muscular+Dystrophy/2962" DB="Genetic Alliance" />
                <XRef ID="111502003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FCMD</ElementValue>
                <XRef Type="MIM" ID="253800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MDDGA4</ElementValue>
                <XRef Type="MIM" ID="253800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Fukuyama congenital muscular dystrophy (FCMD) is characterized by hypotonia, symmetric generalized muscle weakness, and CNS migration disturbances that result in changes consistent with cobblestone lissencephaly with cerebral and cerebellar cortical dysplasia. Mild, typical, and severe phenotypes are recognized. Onset typically occurs in early infancy with poor suck, weak cry, and floppiness. Affected individuals have contractures of the hips, knees, and interphalangeal joints. Later features include myopathic facial appearance, pseudohypertrophy of the calves and forearms, motor and speech delays, intellectual disability, seizures, ophthalmologic abnormalities including visual impairment and retinal dysplasia, and progressive cardiac involvement after age ten years. Swallowing disturbance occurs in individuals with severe FCMD and in individuals older than age ten years, leading to recurrent aspiration pneumonia and death.</Attribute>
                <XRef ID="NBK1206" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6475" />
                <XRef ID="6475" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301385</ID>
                <ID Source="BookShelf">NBK1206</ID>
              </Citation>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <XRef ID="272" DB="Orphanet" />
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C0410174" DB="MedGen" />
              <XRef ID="MONDO:0009678" DB="MONDO" />
              <XRef Type="MIM" ID="253800" DB="OMIM" />
            </Trait>
            <Trait ID="6847" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 4</ElementValue>
                <XRef Type="MIM" ID="613152" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607440.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607440.0009" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, CONGENITAL, FKTN-RELATED</ElementValue>
                <XRef Type="MIM" ID="613152" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4</ElementValue>
                <XRef ID="MONDO:0013156" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDDGB4</ElementValue>
                <XRef Type="MIM" ID="613152" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18456" />
                <XRef ID="18456" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C2751052" DB="MedGen" />
              <XRef ID="MONDO:0013156" DB="MONDO" />
              <XRef Type="MIM" ID="613152" DB="OMIM" />
            </Trait>
            <Trait ID="717" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">FKTN-Related Dilated Cardiomyopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARDIOMYOPATHY, DILATED, WITH MILD OR NO PROXIMAL MUSCLE WEAKNESS</ElementValue>
                <XRef Type="MIM" ID="611615" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dilated cardiomyopathy 1X</ElementValue>
                <XRef ID="MONDO:0012704" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMD1X</ElementValue>
                <XRef Type="MIM" ID="611615" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15522" />
                <XRef ID="15522" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301486</ID>
                <ID Source="BookShelf">NBK1309</ID>
              </Citation>
              <XRef ID="154" DB="Orphanet" />
              <XRef ID="C1969024" DB="MedGen" />
              <XRef ID="MONDO:0012704" DB="MONDO" />
              <XRef Type="MIM" ID="611615" DB="OMIM" />
            </Trait>
            <Trait ID="3235" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy-dystroglycanopathy, type C4</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C4/8753" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4</ElementValue>
                <XRef Type="MIM" ID="611588" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607440.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607440.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607440.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607440.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607440.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2M</ElementValue>
                <XRef ID="MONDO:0012699" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2M</ElementValue>
                <XRef Type="MIM" ID="611588" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MDDGC4</ElementValue>
                <XRef Type="MIM" ID="611588" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LGMD2M</ElementValue>
                <XRef Type="MIM" ID="611588" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12538" />
                <XRef ID="12538" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="206554" DB="Orphanet" />
              <XRef ID="C1969040" DB="MedGen" />
              <XRef ID="MONDO:0012699" DB="MONDO" />
              <XRef Type="MIM" ID="611588" DB="OMIM" />
            </Trait>
            <Trait ID="5116" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT1-RELATED</ElementValue>
                <XRef Type="MIM" ID="236670" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1</ElementValue>
                <XRef ID="MONDO:0009364" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hydrocephalus, agyria and retinal dysplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hard +/- E syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Warburg syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chemke syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pagon syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebroocular dysgenesis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebroocular dysplasia muscular dystrophy syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COD-MD syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDDGA1</ElementValue>
                <XRef Type="MIM" ID="236670" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Walker-Warburg Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">POMT1-Related Muscle Diseases</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C4284790" DB="MedGen" />
              <XRef ID="MONDO:0009364" DB="MONDO" />
              <XRef Type="MIM" ID="236670" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="47333" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41702" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">FKTN-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FKTN-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">FKTN-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="6475" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1903" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4</ElementValue>
                <XRef ID="MONDO:0009678" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, FKTN-RELATED</ElementValue>
                <XRef Type="MIM" ID="253800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, congenital progressive, with mental retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, congenital, with central nervous system involvement</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebromuscular dystrophy, Fukuyama type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fukuyama type muscular dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Walker-Warburg Syndrome, Fktn-Related</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fukuyama congenital muscular dystrophy</ElementValue>
                <XRef ID="Fukuyama+Type+Muscular+Dystrophy/2962" DB="Genetic Alliance" />
                <XRef ID="111502003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FCMD</ElementValue>
                <XRef Type="MIM" ID="253800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MDDGA4</ElementValue>
                <XRef Type="MIM" ID="253800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Fukuyama congenital muscular dystrophy (FCMD) is characterized by hypotonia, symmetric generalized muscle weakness, and CNS migration disturbances that result in changes consistent with cobblestone lissencephaly with cerebral and cerebellar cortical dysplasia. Mild, typical, and severe phenotypes are recognized. Onset typically occurs in early infancy with poor suck, weak cry, and floppiness. Affected individuals have contractures of the hips, knees, and interphalangeal joints. Later features include myopathic facial appearance, pseudohypertrophy of the calves and forearms, motor and speech delays, intellectual disability, seizures, ophthalmologic abnormalities including visual impairment and retinal dysplasia, and progressive cardiac involvement after age ten years. Swallowing disturbance occurs in individuals with severe FCMD and in individuals older than age ten years, leading to recurrent aspiration pneumonia and death.</Attribute>
                <XRef ID="NBK1206" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6475" />
                <XRef ID="6475" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301385</ID>
                <ID Source="BookShelf">NBK1206</ID>
              </Citation>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <XRef ID="272" DB="Orphanet" />
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C0410174" DB="MedGen" />
              <XRef ID="MONDO:0009678" DB="MONDO" />
              <XRef Type="MIM" ID="253800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23514" SubmissionDate="2014-10-03" DateLastUpdated="2014-10-06" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607440.0005_MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4" title="FKTN, 1-BP INS, 1279A_MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4" />
        <ClinVarAccession Accession="SCV000023514" DateUpdated="2014-10-06" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a girl with severe FCMD (MDDGA4; 253800) including microphthalmia, Kondo-Iida et al. (1999) identified a 1-bp insertion (1279insA) in exon 9 of the FKTN gene, causing a frameshift and a premature stop at codon 403. The patient carried the founder insertion (607440.0001) from her mother; however, the 1-bp insertion could not be detected in the father by either SSCP or by direct sequencing, leading Kondo-Iida et al. (1999) to conclude that this was the first example of a de novo mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">10545611</ID>
              </Citation>
              <XRef DB="OMIM" ID="253800" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a cell line from an Ashkenazi Jewish male diagnosed with Walker-Warburg syndrome (MDDGA4), Cotarelo et al. (2008) identified homozygosity for a 1-bp insertion within a stretch of 6 adenine residues in exon 9 (1160_1168insA). Cell lines from the unrelated, unaffected parents revealed that they were heterozygous carriers of the insertion.</Attribute>
              <Citation>
                <ID Source="PubMed">18177472</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs and an unrelated child with FKTN-related limb-girdle muscular dystrophy (MDDGC4; 611588), Godfrey et al. (2006) identified compound heterozygosity for mutations in the FKTN gene. All 3 children had a 1-bp insertion in exon 9 (1167insA), which the authors stated was the same mutation as that identified by Kondo-Iida et al. (1999). The insertion was predicted to result in a frameshift at phe390 and premature termination, followed by nonsense-mediated decay of the mRNA transcript. The second mutant allele identified was a 1-bp deletion (607440.0008) in 1 child and a missense mutation (R307Q; 607440.0009) in 2 sibs. The patients showed early-onset proximal muscular dystrophy, normal intelligence and brain structure, and favorable response to steroid treatment.</Attribute>
              <Citation>
                <ID Source="PubMed">17044012</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10545611</ID>
              </Citation>
              <XRef DB="OMIM" ID="611588" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <Name>FKTN, 1-BP INS, 1279A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1279A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607440.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="23515" SubmissionDate="2014-10-03" DateLastUpdated="2014-10-06" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607440.0005_MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4" title="FKTN, 1-BP INS, 1279A_MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4" />
        <ClinVarAccession Accession="SCV000023515" DateUpdated="2014-10-06" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a girl with severe FCMD (MDDGA4; 253800) including microphthalmia, Kondo-Iida et al. (1999) identified a 1-bp insertion (1279insA) in exon 9 of the FKTN gene, causing a frameshift and a premature stop at codon 403. The patient carried the founder insertion (607440.0001) from her mother; however, the 1-bp insertion could not be detected in the father by either SSCP or by direct sequencing, leading Kondo-Iida et al. (1999) to conclude that this was the first example of a de novo mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">10545611</ID>
              </Citation>
              <XRef DB="OMIM" ID="253800" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a cell line from an Ashkenazi Jewish male diagnosed with Walker-Warburg syndrome (MDDGA4), Cotarelo et al. (2008) identified homozygosity for a 1-bp insertion within a stretch of 6 adenine residues in exon 9 (1160_1168insA). Cell lines from the unrelated, unaffected parents revealed that they were heterozygous carriers of the insertion.</Attribute>
              <Citation>
                <ID Source="PubMed">18177472</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs and an unrelated child with FKTN-related limb-girdle muscular dystrophy (MDDGC4; 611588), Godfrey et al. (2006) identified compound heterozygosity for mutations in the FKTN gene. All 3 children had a 1-bp insertion in exon 9 (1167insA), which the authors stated was the same mutation as that identified by Kondo-Iida et al. (1999). The insertion was predicted to result in a frameshift at phe390 and premature termination, followed by nonsense-mediated decay of the mRNA transcript. The second mutant allele identified was a 1-bp deletion (607440.0008) in 1 child and a missense mutation (R307Q; 607440.0009) in 2 sibs. The patients showed early-onset proximal muscular dystrophy, normal intelligence and brain structure, and favorable response to steroid treatment.</Attribute>
              <Citation>
                <ID Source="PubMed">17044012</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10545611</ID>
              </Citation>
              <XRef DB="OMIM" ID="611588" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <Name>FKTN, 1-BP INS, 1279A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1279A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607440.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1790339" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="833146" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915268" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10545611</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19266496</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17878207</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18177472</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18752264</ID>
          </Citation>
          <Comment>The FKTN c.1167dupA (p.Phe390IlefsTer14) variant results in a frameshift and is predicted to result in premature termination of the protein. Across a selection of the literature, the p.Phe390IlefsTer14 variant has been reported in at least 13 individuals, four of whom are related, diagnosed with a range of conditions. The p.Phe390IlefsTer14 variant was reported to occur de novo in a Japanese individual with a severe Fukuyama congenital muscular dystrophy (FCMD), who also carried the common 3 kb retrotransposal insertion allele in the FKTN gene (Kondo-lida et al. 1999). The variant has also been reported also reported in a compound heterozygous state in three individuals presenting with a limb girdle muscular dystrophy with no intellectual disability or brain abnormalities; two of the individuals are related and carry the variant in trans with a missense variant while the third carried the variant in trans with a second frameshift variant (Godfrey et al. 2006). Additionally the p.Phe390IlefsTer14 variant has been reported in a homozygous state in nine individuals with Walker-Warburg syndrome, a more severe phenotype, all of whom are of Ashkenazi Jewish ancestry from non-consanguineous families and share a common haplotype. The variant was detected in two or 299 alleles in a healthy American Ashkenazi Jewish control population suggesting this may be a founder variant in this population (Cotarelo et al. 2008; Manzini et al. 2008; Chang et al. 2009). The p.Phe390IlefsTer14 variant is reported at a frequency of 0.007991 in the Ashkenazi Jewish population of the Genome Aggregation Database. Based on the collective evidence and potential impact of frameshift variants, the p.Phe390IlefsTer14 variant is classified as pathogenic for FKTN-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="9" alternateAllele="GA" referenceAllele="G" start="108382330" stop="108382330" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001079802.1:c.1167dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FKTN-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2292270" SubmissionDate="2019-09-27" DateLastUpdated="2020-02-28" DateCreated="2020-02-28">
        <ClinVarSubmissionID localKey="NC_000009.11:g.108382337dupA|OMIM:253800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001163214" DateUpdated="2020-02-28" DateCreated="2020-02-28" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.108382337dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BG_GA_2018_SNVs_INDELS</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2354383" SubmissionDate="2020-06-18" DateLastUpdated="2020-07-03" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey="25858|OMIM:253800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001193928" DateUpdated="2020-07-03" DateCreated="2020-04-06" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000485175" DateChanged="2020-07-02" Version="1">
            <Comment Type="MergeComment">SCV000485175 was merged into SCV001193928 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2019-11-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19266496</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18752264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17878207</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10545611</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18177472</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24144914</ID>
          </Citation>
          <Comment>NM_001079802.1(FKTN):c.1167dupA(F390Ifs*14) is classified as pathogenic in the context of FKTN-related disorders. Sources cited for classification include the following: PMID 19266496, 18752264, 17878207, 10545611, 18177472 and 24144914. Classification of NM_001079802.1(FKTN):c.1167dupA(F390Ifs*14) is based on the following criteria: The variant causes a premature termination codon that is not expected to be targeted by nonsense-mediated mRNA decay; however, literature evidence strongly supports pathogenicity. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/vlxza0ea/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2019_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="9" alternateAllele="GA" referenceAllele="G" start="108382330" stop="108382330" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6849778</SubmissionName>
          <SubmissionName>SUB7605676</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2861112" SubmissionDate="2020-09-02" DateLastUpdated="2020-12-12" DateCreated="2020-12-12">
        <ClinVarSubmissionID localKey="2073755|Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001448834" DateUpdated="2020-12-12" DateCreated="2020-12-12" Type="SCV" Version="1" SubmitterName="Knight Diagnostic Laboratories, Oregon Health and Sciences University" OrgID="505542" OrganizationCategory="laboratory" OrgAbbreviation="KDL-OHSU" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-03-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Language impairment</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002463" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Delayed speech and language development</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000750" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Neurological speech impairment</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002167" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Global developmental delay</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001263" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Failure to thrive</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001508" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Short stature</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0004322" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Expressive language delay</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002474" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Receptive language delay</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0010863" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Muscular hypotonia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001252" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Generalized muscle weakness</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0003324" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the immune system</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002715" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the fetal cardiovascular system</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0010948" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="9" alternateAllele="GA" referenceAllele="G" start="108382330" stop="108382330" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <Name>
              <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7918263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5412835" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_006731_2_FKTN_c_1167dupA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002767381" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19266496</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type 4A (MIM#253800). (I) 0106 - This gene is associated with autosomal recessive disease. Recessive pathogenic variants in this gene can cause three types of muscular dystrophy-dystroglycanopathy: a severe congenital form with brain and eye anomalies (type A4; MIM# 253800), formerly designated Fukuyama congenital muscular dystrophy (FCMD), Walker-Warburg syndrome (WWS), or muscle-eye-brain disease (MEB), a less severe congenital form without impaired intellectual development (type B4; MIM# 613152), and a milder limb-girdle form (type C4; MIM# 611588). (I) 0205 - Variant is predicted to result in a truncated protein (premature termination codon is NOT located at least 54 nucleotides upstream of the final exon-exon junction) with less than 1/3 of the protein sequence affected. (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) &lt;0.01 for a recessive condition (97 heterozygotes, 0 homozygotes) and is enriched in the Ashkenazi Jewish population. (SP) 0604 - Variant is not predicted to truncate an established domain, motif, hotspot or informative constraint region. (I) 0702 - Other truncating variants comparable to the one identified in this case have strong previous evidence for pathogenicity. At least three downstream truncating variants have previously been classified as pathogenic (ClinVar, DECIPHER). (SP) 0801 - This variant has very strong previous evidence of pathogenicity in unrelated individuals. The variant has previously been reported as pathogenic in many individuals with muscular dystrophy-dystroglycanopathies and is considered to be a founder variant in the Ashkenazi Jewish population. When homozygous, the variant results in the severe congenital type 4A form of disease with brain and eye anomalies (MIM#253800), however the type can vary when in compound heterozygosity with a different variant (ClinVar, LOVD, PMID: 19266496). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_6553</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006731.2:c.1167dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5429163" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_001079802.2:c.1167dup|OMIM:236670;253800;611588;611615;613152" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002776954" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001079802.2:c.1167dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="236670" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253800" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611588" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611615" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613152" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3964719" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="045276d2edf55ddc68ff9be0312e65c14d29ad0c38b123efbad51205e9ca0910|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002023727" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001079802.1:c.1167dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1464815" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="208865|MedGen:C0265221" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000755359" DateUpdated="2024-02-20" DateCreated="2018-05-28" Type="SCV" Version="7" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17878207</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18177472</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18752264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19266496</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27065010</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe390Ilefs*14) in the FKTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 72 amino acid(s) of the FKTN protein. This variant is present in population databases (rs756763804, gnomAD 0.8%). This premature translational stop signal has been observed in individual(s) with dystroglycanopathies (PMID: 17878207, 18177472, 18752264, 19266496, 27065010). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 3203). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.108382330_108382331insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265221" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1365068" SubmissionDate="2018-01-25" DateLastUpdated="2017-01-06" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="NM_006731.2:c.1167dupA|MedGen:C0410174" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000698716" DateUpdated="2017-01-06" DateCreated="2017-01-06" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18177472</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17878207</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="398123555" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006731.2:c.1167dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0410174" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="644550" SubmissionDate="2016-11-03" DateLastUpdated="2019-07-30" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="5944_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000331176" DateUpdated="2019-07-30" DateCreated="2016-12-06" Type="SCV" Version="3" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000111306" DateChanged="2018-02-14" Version="5" />
        </ReplacedList>
        <Classification DateLastEvaluated="2012-12-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation Type="general">
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="7" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="7" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="9" alternateAllele="A" referenceAllele="-" start="108382337" stop="108382338" variantLength="2" />
            <GeneLocation>NM_001079802.1:Ex10</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI992789" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">23757202</ID>
        </Citation>
        <Citation>
          <URL>http://geneticslab.emory.edu/emvclass/emvclass.php?approved_symbol=FKTN</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL001</SubmissionName>
          <SubmissionName>EGL002</SubmissionName>
          <SubmissionName>EGL004</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4072753" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_001079802.2:c.1167dup|Walker-Warburg congenital muscular dystrophy" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002081970" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-03">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001079802.2:c.1167dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Walker-Warburg congenital muscular dystrophy</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5114328" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a08768|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002629460" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10545611</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17044012</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18177472</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19266496</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24144914</ID>
          </Citation>
          <Comment>The c.1167dupA pathogenic mutation, located in coding exon 8 of the FKTN gene, results from a duplication of A at nucleotide position 1167, causing a translational frameshift with a predicted alternate stop codon (p.F390Ifs*14). This alteration occurs at the 3' terminus of theFKTN gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 15% of the protein. However, premature stop codons are typically deleterious in nature, a significant portion of the protein is affected, and the impacted region is critical for protein function (Ambry internal data). This mutation has been detected in both the compound heterozygous and homozygous states in individuals with Fukuyama congenital muscular dystrophy (FCMD) and Walker-Warburg syndrome (WWS). In addition, this mutation is present in 0.8% of healthy Ashkenazi Jewish individuals, and often occurs on one specific haplotype, suggesting it may be a founder mutation in this population (Kondo-Iida E et al. Hum. Mol. Genet., 1999 Nov;8:2303-9; Chang W et al. Prenat. Diagn., 2009 Jun;29:560-9; Cotarelo RP et al. Clin. Genet., 2008 Feb;73:139-45; Godfrey C et al. Ann. Neurol., 2006 Nov;60:603-10). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001079802.1:c.1167dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7845081" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_001079802.2:c.1167dup|OMIM:611615" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004199715" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001079802.2:c.1167dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611615" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="643157" SubmissionDate="2024-07-17" DateLastUpdated="2024-07-23" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDXSV:479815" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000329807" DateUpdated="2024-07-23" DateCreated="2016-12-06" Type="SCV" Version="9" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-04-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation, as the last 72 amino acids are replaced with 13 different amino acids, and other loss-of-function variants have been reported downstream in HGMD; Reported in association with Fukuyama congenital muscular dystrophy (FCMD), limb girdle muscular dystrophy (LGMD), and Walker-Warburg syndrome (WWS) (PMID: 17044012, 10545611, 18177472, 18752264, 19266496); Reported with a second variant in the FKTN gene in a patient with dilated cardiomyopathy; however, segregation information was not provided (PMID: 32746448); Founder mutation in the Ashkenazi Jewish population, present in 81/10350 (0.78%) alleles from individuals of Ashkenazi Jewish ancestry in large population cohorts (gnomAD; PMID: 18177472, 19266496, 18752264); Reported in ClinVar but additional evidence is not available (ClinVar Variant ID# 3203; ClinVar); This variant is associated with the following publications: (PMID: 18752264, 18177472, 19266496, 20961758, 10545611, 27065010, 29327352, 31980526, 32746448, 17044012)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:667189</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001079802.1:c.1167dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_123_20220810054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_150_20221214054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_313_20240717054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_50_20210924044205</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2292270" TraitType="Disease" MappingType="XRef" MappingValue="253800" MappingRef="OMIM">
        <MedGen CUI="C0410174" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="643157" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2861112" TraitType="Finding" MappingType="Name" MappingValue="Failure to thrive" MappingRef="Preferred">
        <MedGen CUI="C2315100" Name="Failure to thrive" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429163" TraitType="Disease" MappingType="XRef" MappingValue="611588" MappingRef="OMIM">
        <MedGen CUI="C1969040" Name="Autosomal recessive limb-girdle muscular dystrophy type 2M" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429163" TraitType="Disease" MappingType="XRef" MappingValue="253800" MappingRef="OMIM">
        <MedGen CUI="C0410174" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2861112" TraitType="Finding" MappingType="Name" MappingValue="Short stature" MappingRef="Preferred">
        <MedGen CUI="C0349588" Name="Short stature" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="644550" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1464815" TraitType="Disease" MappingType="XRef" MappingValue="C0265221" MappingRef="MedGen">
        <MedGen CUI="C0265221" Name="Walker-Warburg congenital muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429163" TraitType="Disease" MappingType="XRef" MappingValue="611615" MappingRef="OMIM">
        <MedGen CUI="C1969024" Name="Dilated cardiomyopathy 1X" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7845081" TraitType="Disease" MappingType="XRef" MappingValue="611615" MappingRef="OMIM">
        <MedGen CUI="C1969024" Name="Dilated cardiomyopathy 1X" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429163" TraitType="Disease" MappingType="XRef" MappingValue="236670" MappingRef="OMIM">
        <MedGen CUI="C4284790" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2354383" TraitType="Disease" MappingType="XRef" MappingValue="253800" MappingRef="OMIM">
        <MedGen CUI="C0410174" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2861112" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of the immune system" MappingRef="Preferred">
        <MedGen CUI="C4021753" Name="Abnormality of the immune system" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2861112" TraitType="Finding" MappingType="Name" MappingValue="Global developmental delay" MappingRef="Preferred">
        <MedGen CUI="C0557874" Name="Global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1365068" TraitType="Disease" MappingType="XRef" MappingValue="C0410174" MappingRef="MedGen">
        <MedGen CUI="C0410174" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2861112" TraitType="Finding" MappingType="Name" MappingValue="Generalized muscle weakness" MappingRef="Preferred">
        <MedGen CUI="C0746674" Name="Generalized muscle weakness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="23514" TraitType="Disease" MappingType="Name" MappingValue="MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4" MappingRef="Preferred">
        <MedGen CUI="C0410174" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2861112" TraitType="Finding" MappingType="Name" MappingValue="Expressive language delay" MappingRef="Preferred">
        <MedGen CUI="C0454641" Name="Expressive language delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2861112" TraitType="Finding" MappingType="Name" MappingValue="Language impairment" MappingRef="Preferred">
        <MedGen CUI="C0023015" Name="Language disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2861112" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of the fetal cardiovascular system" MappingRef="Preferred">
        <MedGen CUI="C4021210" Name="Abnormal fetal cardiovascular morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5429163" TraitType="Disease" MappingType="XRef" MappingValue="613152" MappingRef="OMIM">
        <MedGen CUI="C2751052" Name="Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5412835" TraitType="Disease" MappingType="XRef" MappingValue="253800" MappingRef="OMIM">
        <MedGen CUI="C0410174" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5114328" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="23515" TraitType="Disease" MappingType="Name" MappingValue="MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4" MappingRef="Alternate">
        <MedGen CUI="C1969040" Name="Autosomal recessive limb-girdle muscular dystrophy type 2M" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2861112" TraitType="Finding" MappingType="Name" MappingValue="Neurological speech impairment" MappingRef="Preferred">
        <MedGen CUI="C0037822" Name="Abnormality of speech or vocalization" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2861112" TraitType="Finding" MappingType="Name" MappingValue="Receptive language delay" MappingRef="Preferred">
        <MedGen CUI="C0454642" Name="Receptive language delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2861112" TraitType="Finding" MappingType="Name" MappingValue="Delayed speech and language development" MappingRef="Preferred">
        <MedGen CUI="C0454644" Name="Delayed speech and language development" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4072753" TraitType="Disease" MappingType="Name" MappingValue="Walker-Warburg congenital muscular dystrophy" MappingRef="Preferred">
        <MedGen CUI="C0265221" Name="Walker-Warburg congenital muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3964719" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2861112" TraitType="Finding" MappingType="Name" MappingValue="Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4" MappingRef="Preferred">
        <MedGen CUI="C1969040" Name="Autosomal recessive limb-girdle muscular dystrophy type 2M" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2861112" TraitType="Finding" MappingType="Name" MappingValue="Muscular hypotonia" MappingRef="Preferred">
        <MedGen CUI="C0026827" Name="Hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1790339" TraitType="Disease" MappingType="Name" MappingValue="FKTN-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="FKTN-related disorder" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-06-21">SCV001529439</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

